ARX 8-K Filed 2026-08-13 Execution disclosure

Accelerant repurchased 4.7M shares for $66M in Q2 2026

Insurance marketplace platform executed buyback ahead of Thoma Bravo acquisition; $123M remains authorized.

Shares repurchased4.7M
Avg price paid$13.96
Remaining$123M
MechanismNot specified

What the filing says

Accelerant Holdings (NYSE: ARX) repurchased 4,725,968 Class A common shares for $66 million during the second quarter ended June 30, 2026, according to the company's earnings announcement filed as an 8-K exhibit. The company disclosed that approximately $123 million of remaining authorization remains under its share repurchase program following the Q2 execution.

The buyback was conducted under the company's existing authorization, though the filing does not specify the execution mechanism (Rule 10b-18 open-market purchases, 10b5-1 plan, or other method). The repurchase represents a share count reduction of approximately 4.1% against the current diluted share base of roughly 219.7 million shares outstanding as of Q2 2026.

The buyback was executed during a period of strong operational performance. Accelerant reported exchange written premium of $1.32 billion in Q2 (up 23% year-over-year), pre-tax income of $87 million, and adjusted EBITDA of $93.1 million. However, the company subsequently announced a definitive agreement to be acquired by private-equity firm Thoma Bravo, and accordingly cancelled its scheduled Q2 earnings conference call and suspended forward guidance.

Repurchased 4,725,968 Class A common shares for $66 million; the company has approximately $123 million of remaining authorization under its share repurchase program — Accelerant Holdings 8-K filing  ·  View on SEC EDGAR →

What this means

The $66 million buyback in Q2 reduced Accelerant's diluted share count by approximately 2.1% for the quarter. With $123 million of authorization remaining, the company could theoretically repurchase an additional 8.8 million shares at the Q2 average price. However, the pending Thoma Bravo acquisition materially constrains future buyback activity. Under typical deal conditions, open-market repurchases are suspended during the pendency of a material transaction. The buyback execution during a period when acquisition negotiations were likely underway reflects share-count management in a strong operating environment, though investors should expect minimal additional repurchase activity prior to deal closing.

Frequently asked questions

How much did Accelerant pay per share in Q2 2026?
The company repurchased 4.7 million shares for $66 million, implying an average price of approximately $13.96 per share. This represents the execution price paid during the second quarter repurchase program.
How much buyback authorization remains?
Accelerant disclosed approximately $123 million of remaining authorization under its share repurchase program as of the Q2 2026 earnings announcement. This authorization is available for future repurchases, though execution is expected to be limited pending the Thoma Bravo acquisition.
What happens to the buyback program given the Thoma Bravo transaction?
The company announced a definitive agreement to be acquired by Thoma Bravo in August 2026. Open-market buybacks are typically suspended during the pendency of a material acquisition. Any remaining authorization would likely be cancelled or absorbed in the transaction closing.
Did the filing disclose the buyback execution method?
No, the filing does not specify whether repurchases were executed under Rule 10b-18 open-market purchases, a 10b5-1 trading plan, or another mechanism. Only the aggregate shares and dollar amount are disclosed in this earnings announcement.
What was Accelerant's Q2 operational performance?
Accelerant reported exchange written premium of $1.32 billion (up 23% year-over-year), pre-tax income of $87 million, net income of $80 million, and adjusted EBITDA of $93.1 million with a margin of 30.6%. Third-party direct premium represented 47% of exchange volume.
How does the buyback compare to Accelerant's market cap?
The $66 million Q2 repurchase represents approximately 0.3–0.5% of the company's implied equity value prior to the Thoma Bravo acquisition announcement. The buyback was modest in relation to the company's earnings power and financial position at the time of execution.
execution tech-sector insurance Q2-2026 rule-10b18-likely pending-acquisition
Source. This editorial summary is based on the SEC filing linked above. BuybackStocks aggregates and editorializes publicly available SEC EDGAR filings. Not investment advice. Past authorization announcements do not guarantee future repurchase activity or share price performance. See our full disclosures policy.